Clinical Trial Update: A Clinical Trial Comparing the BAGUERA C to the Marketed Mobi-C® for the Treatment of Single Level Cervical Disc Disease [NA]

View source ↗

Summary

A clinical trial comparing the BAGUERA C cervical disc to the marketed Mobi-C for single-level cervical disc disease is ongoing, with status listed as Unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Disc Disease

Drugs mentioned

• BAGUERA C
• Mobi-C

Snippet

Sponsor: Spineart USA | Conditions: Cervical Disc Disease | NA | Status: UNKNOWN